UNSPSC 51142422: Oxetorone
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51142400
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51142422
Definition
This classification denotes a serotonin antagonist with the molecular formula C21H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T3XOS33TIQ, chemically known as 3-(12h-benzofuro(3,2-c)(1)benzoxepin-6-yliden)-n,n-dimethylpropylamin but generally known as oxetorone, which bears US NIH Compound Identifier 6436540. European Medicines Agency schedules Oxetorone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09518MIG.
Read the full definition
The term OXETORONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules oxetorone in its Anatomical Therapeutic Chemical (ATC) Classification. OXETORONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxetorone under HS 29329985 and SITC 51569. As of Q4 2014, OXETORONE remains the US FDA Preferred Term for this commodity. Oxetorone bears US NLM identifiers UMLS ID C0069760 and NCI Concept Code C84037.
SMILES: O1C2C(C3C1CCCC3)COC1C(C\2=C\CCN(C)C)CCCC1.
About UNSPSC 51142422
UNSPSC 51142422 Oxetorone (Commodity) does not align with the recent state and local procurement activity tagged under this code. The three opportunities posted since April 2026 solicit naloxone and drug deactivation systems, therapeutic pharmacy initiative direct-to-manufacturer prescriptions, and generic multi-source pharmaceuticals and OTC products — none of which are oxetorone, a chemical intermediate used in pharmaceutical synthesis. The code appears to be a mislabeling artifact within the state and local procurement system; oxetorone itself does not surface in recent state or local solicitations reviewed.
The misaligned opportunities reveal that issuing bodies tagging this code actually seek pharmaceutical supply, pharmacy benefit management services, and medical countermeasure distribution. Seminole County, Florida (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) procures 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to its Community Health Building. The Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) is gathering market intelligence on direct-to-manufacturer prescription programs outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (RFP S1070000015802, posted January 20, 2026, due March 26, 2026) seeks generic pharmaceuticals and OTC products through authorized wholesalers for statewide and multi-state distribution, with awards effective July 1, 2026. Activity is concentrated in Florida, Texas, and Minnesota, though MMCAP's cooperative purchasing structure spans multiple state and local participants. Do not pursue opportunities under this code without verifying the actual commodity or service being solicited; the taxonomy tag does not reflect the work being bought.
Quick answers
What is UNSPSC 51142422?
UNSPSC 51142422 is Oxetorone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51142422?
UNSPSC 51142422 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51142422
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code